TESTING
TREATMENTS - BETTER RESEARCH
FOR BETTER HEALTHCARE
By Imogen
Evans, Hazel Thornton, and Iain Chalmers
REFERENCES 31 - 60
31 Thornton H. The screening debates: time for a broader approach?
European Journal of
Cancer 2003;39:1807–9.
32 Adapted from Wilson JMG, Jungner G. Principles and practice of
screening for
disease. Public health paper no 34. Geneva: World Health Organisation,
1968.
33 Gray JAM. Evidence-based healthcare. Edinburgh: Churchill
Livingstone, 1997.
34 Morris JK. Screening for neuroblastoma in children. Journal of
Medical Screening
2002;9:56.
35 Welch HG. Should I be tested for cancer? Maybe not and here’s why.
Berkeley and Los
Angeles: University of California Press, 2004. p77.
36 Morris JK. Screening for neuroblastoma in children. Journal of
Medical Screening 2002;9:56.
37 Hummel S, Paisley S, Morgan A, et al. Clinical and
cost-effectiveness of new and
emerging technologies for early localised prostate cancer: a systematic
review.
Health Technology Assessment Report 2003; volume 7, no. 33.
38 Law M. Screening without evidence of efficacy. British Medical
Journal 2004;328:301–2.
39 Yamey G, Wilkes M. The PSA storm. British Medical Journal
2002;324:431.
40 Wallis C. Atypical cystic fibrosis – diagnostic and management
dilemmas. Journal of
the Royal Society of Medicine 2003;96(suppl 43):2–10.
41 David TJ. Newborn screening for cystic fibrosis. Journal of the
Royal Society of Medicine
2004;97: 209–10.
42 Farrell MH, Farrell PM. Newborn screening for cystic fibrosis:
ensuring more good
than harm. Journal of Pediatrics 2003;143:707–12.
43 NICE. Guidance on the removal of wisdom teeth, 2000. Available from:
www.nice.org.uk/page.aspx?o=526 [accessed 4 December 2005].
44 Allen C, Glasziou P, Del Mar C. Bed rest: a potentially harmful
treatment needing
more careful evaluation. Lancet 1999;354:1229–33.
45 Antman EM, Lau J, Kupelnick B, Mosteller F, Chalmers TC. A
comparison of results of meta-analysis of randomized control trials and
recommendations of clinical experts. Journal of the American Medical
Association 1992;268:240–8.
46 Asher R. Talking sense (Lettsonian lecture, 16 Feb, 1959).
Transactions of the Medical Society of London, vol LXXV, 1958–59.
Reproduced in: Jones, FA, ed. Richard Asher talking sense. London:
Pitman Medical, 1972.
47 Noseworthy JH, Ebers GC, Vandervoort MK, et al. The impact of
blinding on the results of a randomized, placebo-controlled multiple
sclerosis clinical trial. Neurology 1994;44:16–20.
48 Antiplatelet Trialists’ Collaborative Group. Collaborative overview
of randomised trials of antiplatelet therapy. British Medical Journal
1994;308:81–106.
49 Beral V, for the Million Women Study Collaborators. Breast cancer
and hormonereplacement therapy in the Million Women Study. Lancet
2003;362:419–27.
50 Address by the Rt. Hon. Lord Rayleigh. In: Report of the
fifty-fourth meeting of the British Association for the Advancement of
Science; held at Montreal in August and September 1884, London: John
Murray, pp3–23.
51 Reynolds LA, Tansey EM, eds. Prenatal corticosteroids for reducing
morbidity and mortality after preterm birth. London: Wellcome Trust
Centre for the History of Medicine, 2005.
52 Lindley RI. Personal communication, 2005.
53 Druker BJ, Talpaz M, Resta DJ, et al. Efficacy and safety of a
specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid
leukemia. New England Journal of Medicine 2001;344:1031–7.
54 Loudon I. The use of historical controls and concurrent controls to
assess the effects of sulphonamides, 1936–1945. Available from:
www.jameslindlibrary.org [accessed 3 January 2006].
55 Transurethral resection of the prostate for benign prostatic
hyperplasia. In: Wennburg JE, McAndrew Cooper M, eds. The Dartmouth
Atlas of Healthcare in the United States. Hanover, New Hampshire:
Center for Evaluative Clinical Sciences, Dartmouth Medical School,
1996, p142. The 1996 edition and the updated 1999 edition are available
from: www.dartmouthatlas.org/atlases/atlas_series.shtm [accessed 29
December 2005].
56 Burton MJ, Towler B, Glasziou P. Tonsillectomy versus non-surgical
treatment for
chronic/recurrent acute tonsillitis. The Cochrane Database of
Systematic Reviews 1999,
Issue 3. Art. No.: CD001802. Available from: www.thecochranelibrary.com
[accessed 3 January 2006].
57 Ashcroft R. Giving medicine a fair trial. British Medical Journal
2000;320:1686.
58 Smithells RW. Iatrogenic hazards and their effects. Postgraduate
Medical Journal
1975;15:39–52.
59 General Medical Council. Seeking patients’ consent: the ethical
considerations. November 1998. Available from:
www.gmc-uk.org/guidance/library/consent.asp [accessed 6 December 2005].
60 Chalmers I, Lindley R. Double standards on informed consent to
treatment. In: Doyal L, Tobias JS, eds. Informed consent in medical
research. London: BMJ Books 2001, pp266–75.
|
